Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using megestrol
may fight liver cancer by blocking the uptake of estrogen. It is not yet known if megestrol
is an effective treatment for liver cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in treating
patients who have liver cancer that cannot be removed by surgery.
Phase:
Phase 3
Details
Lead Sponsor:
National Medical Research Council (NMRC), Singapore